I introduce myself to patients as Ben

Publication
Article
Optometry Times JournalVol. 11 No. 5
Volume 11
Issue 5

I’ve been called many things in my life, some worse than others. In my office, I’m colloquially known as Dr. Ben (Dr. Casella being my father). Patients know me by numerous names: Dr. Ben, Dr. Benjamin, or my favorite, “Mr. Benjy,” as one patient prefers.

I usually introduce myself as Ben. Simple. Blunt. To the point.

When people ask me what I do, I usually tell them that I am an optometrist. In print, I prefer the term “doctor of optometry,” because I think it is more descriptive of what it is I actually do. The term “doctor” is designated to persons who have earned a higher education degree deemed fit by the governing bodies responsible for designating said term.

“Doctor of optometry” seems to hold clout and merit in society, and it should. We work hard to earn these degrees, right? We don’t earn them for the pieces of paper hanging on our walls explaining to people what we are. We earn them so that we can care for the eyes and vision of the public.

Previously by Dr. Casella: Interest growing in virtual CE

Ms., not Dr.
I began thinking about this topic because I stumbled across a newspaper article some time back that was written by someone who doesn’t care much for optometry. I won’t tell you where or when because, frankly, I don’t think it’s worth the read.

However, I will tell you that it was a propaganda piece put into a local newspaper and written by an educated individual who repeatedly referred to a doctor of optometry as “Ms.” and not “Dr.” There was no typographical error. There was no oversight. It was just a cheap shot and an attempt to garner negative sentiment on the part of the public in a state which was undergoing a scope expansion battle at the time.

Related: Legislative session offers opportunity to join in

Still needed in 2019
So, what can I do about such tactics? The lazy answer is nothing.

The correct answer is that I can educate the public about what I do and how I was taught (and continue to be taught). To think that this is still necessary in 2019 is nuts to many, but it’s a simple truth.

In the meantime, I’ll probably still introduce myself to my patients as Ben, however incorrect that may seem. Whenever people attempt to explain to me what I do-but really have no idea-I’ll ask them if they’ve ever visited a school of optometry or even taken the time to skim through a school of optometry’s curriculum. After a long second of silence, I usually say, “I’ll wait for you to do so if you’d like.”

How do you refer to yourself? Do you have patients who address you with monikers like “Mr. Benjy” who you simply ignore because correcting them would do more harm than good?

I want to know! So, reach out to us on Twitter at @OptometryTimes and share your nomenclature.

Read more editorials here

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.